Table 4.

The baseline characteristics of the study participants.

Items	All (n = 33)
Age	40.5 ± 12.0
Sex (M/F)	22/11
Duration of disease (years)	7.3 ± 5.4
Disease location
Proctitis	4
Left-sided colitis	14
Extensive colitis	15
Total Mayo score	7.12 ± 1.9
Mild: 3–5	8
Moderate: 6–10	25
Sum endoscopic mayo score	6.5 ± 4.2
Ongoing treatment
5-ASA	30
Corticosteroid	2
Azathioprine	4
Vedolizumab	1
Anti-TNF	3

5-ASA, 5-aminosalicylic acid; Anti-TNF, anti-tumor necrosis factor.